Discovery and validation of a protein biomarker for the diagnosis and classification of disease severity of major depressive disorder.

[1]  T. Suppes,et al.  Novel and emerging treatments for major depression , 2022, The Lancet.

[2]  E. Joo,et al.  Discovery and validation of acetyl-L-carnitine in serum for diagnosis of major depressive disorder and remission status through metabolomic approach , 2022, Frontiers in Psychiatry.

[3]  G. Fries,et al.  Molecular pathways of major depressive disorder converge on the synapse , 2022, Molecular Psychiatry.

[4]  E. Joo,et al.  Serum proteomic analysis of major depressive disorder patients and their remission status: Novel biomarker set of zinc-alpha-2-glycoprotein and keratin type II cytoskeletal 1. , 2021, International journal of biological macromolecules.

[5]  E. Joo,et al.  Discovery of Screening Biomarkers for Major Depressive Disorder in Remission by Proteomic Approach , 2021, Diagnostics.

[6]  M. Chatterjee,et al.  Comparative Platelet Releasate Proteomic Profiling of Acute Coronary Syndrome versus Stable Coronary Artery Disease , 2020, Frontiers in Cardiovascular Medicine.

[7]  P. Collier,et al.  Tetranectin, a potential novel diagnostic biomarker of heart failure, is expressed within the myocardium and associates with cardiac fibrosis , 2020, Scientific Reports.

[8]  P. Chanson,et al.  Peripheral tryptophan, serotonin, kynurenine, and their metabolites in major depression: A case–control study , 2019, Psychiatry and clinical neurosciences.

[9]  Philipp E. Geyer,et al.  Proteomics for blood biomarker exploration of severe mental illness: pitfalls of the past and potential for the future , 2018, Translational Psychiatry.

[10]  Ian J. Baguley,et al.  Understanding the pathophysiology of depression: From monoamines to the neurogenesis hypothesis model - are we there yet? , 2018, Behavioural Brain Research.

[11]  J. Jiang,et al.  iTRAQ technology-based identification of human peripheral serum proteins associated with depression , 2016, Neuroscience.

[12]  J. Bilello,et al.  Seeking an objective diagnosis of depression. , 2016, Biomarkers in medicine.

[13]  B. Penninx,et al.  Serum biomarkers predictive of depressive episodes in panic disorder. , 2016, Journal of psychiatric research.

[14]  Ruiyan Zhang,et al.  Tetranectin as a Potential Biomarker for Stable Coronary Artery Disease , 2015, Scientific Reports.

[15]  Hookeun Lee,et al.  Proteomic Analysis of Serum from Patients with Major Depressive Disorder to Compare Their Depressive and Remission Statuses , 2015, Psychiatry investigation.

[16]  Ronald S Duman,et al.  Functional Biomarkers of Depression: Diagnosis, Treatment, and Pathophysiology , 2011, Neuropsychopharmacology.

[17]  V. Starcevic,et al.  Reliability of the Hamilton Rating Scale for Depression: A meta-analysis over a period of 49years , 2011, Psychiatry Research.

[18]  Serge Marchand,et al.  A Deficit in Peripheral Serotonin Levels in Major Depressive Disorder but Not in Chronic Widespread Pain , 2011, The Clinical journal of pain.

[19]  J. Loo,et al.  Identification of Tetranectin as a Potential Biomarker for Metastatic Oral Cancer , 2010, International journal of molecular sciences.

[20]  H. Deckmyn,et al.  Antiplatelet drugs , 2008, British journal of haematology.

[21]  R. Bagby,et al.  The Hamilton Depression Rating Scale: has the gold standard become a lead weight? , 2004, The American journal of psychiatry.

[22]  E. Maurer-Spurej,et al.  The influence of selective serotonin reuptake inhibitors on human platelet serotonin , 2003, Thrombosis and Haemostasis.

[23]  Søren M. Bentzen,et al.  Plasma tetranectin and colorectal cancer. , 1995, European journal of cancer.

[24]  M. Costa,et al.  Neurons with 5-hydroxytryptamine-like immunoreactivity in the enteric nervous system: Their projections in the guinea-pig small intestine , 1982, Neuroscience.

[25]  A. Coppen.  The Biochemistry of Affective Disorders , 1967, British Journal of Psychiatry.

[26]  L. Kriston,et al.  Not as golden as standards should be: interpretation of the Hamilton Rating Scale for Depression. , 2011, Journal of affective disorders.

[27]  A. Cleare,et al.  Reduced whole blood serotonin in major depression , 1997, Depression and anxiety.

[28]  H Wetzel,et al.  Improving depression severity assessment--I. Reliability, internal validity and sensitivity to change of three observer depression scales. , 1988, Journal of psychiatric research.